Kogan A D, Orenstein S
Department of Medicine, Loyola University, Evanston 60202.
Postgrad Med J. 1990 Apr;66(774):294-6. doi: 10.1136/pgmj.66.774.294.
Severe rhabdomyolysis complicated by respiratory and renal failure developed three weeks after initiation of low dose lovastatin therapy in a 79 year old, non-immunocompromised patient. The concomitant use of gemfibrozil may increase the risk of this complication.
一名79岁、无免疫功能低下的患者在开始低剂量洛伐他汀治疗三周后出现严重横纹肌溶解,并伴有呼吸和肾衰竭。同时使用吉非贝齐可能会增加这种并发症的风险。